Asthma and comorbidities

Current Opinion in Allergy and Clinical Immunology

Volumn 13, Issue 1, 2013, Pages 78-86

  Ledford, Dennis K ^a   Lockey, Richard F ^b,c  

^a James A Haley VA Hospital   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

asthma; asthma control; comorbidities

Indexed keywords

ALLERGEN; IMMUNOSTIMULATING AGENT; LEUKOTRIENE MODIFIER; OMALIZUMAB; UNCLASSIFIED DRUG;

ALLERGY; ANXIETY; ASTHMA; BRONCHOPNEUMONIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONNECTIVE TISSUE DISEASE; DEPRESSION; DISEASE ASSOCIATION; DISEASE EXACERBATION; ECZEMA; EVIDENCE BASED MEDICINE; GASTROESOPHAGEAL REFLUX; HUMAN; IMMUNOPATHOLOGY; IMMUNOTHERAPY; LARYNGOSCOPY; LUNG INFECTION; METABOLIC DISORDER; NEUROLOGIC DISEASE; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHINITIS; RHINOSINUSITIS; VOCAL CORD DISORDER;

ANXIETY; ASTHMA; COMORBIDITY; GASTROESOPHAGEAL REFLUX; HUMANS; OBESITY; RESPIRATORY SOUNDS; VOCAL CORDS;

EID: 84871997753     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32835c16b6     Document Type: Review

References (53)

1. Demoly P, Gueron B, Annunziata K, et al. Update on asthma control in five European countries: results of a 2008 survey. Eur Respir Rev 2010; 19:150-157.
2. Fuhlbrigge A, Reed ML, Stempel DA, et al. The status of asthma control in the U.S. adult population. Allergy Asthma Proc 2009; 30:529-533.
3. Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J 2009; 33:897-906.
4. Thomas M, Price D. Impact of co-morbidities on asthma. Expert Rev Clin Immunol 2008; 4:731-742.
5. ten Brinke A, Sterk PJ, Masclee AA, et al. Risk factors of frequent exacer-bations in difficult-to-treat asthma. Eur Respir J 2007; 26:812-818.
6. Gershon AS, Guan J, Wang C, et al. Describing and quantifying asthma comorbidity: a population study. Plos One 2012; 7:e34967.
7. Bresciani M, Paradis L, Des Roches A, et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol 2001; 107:73-80.
8. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2) LEN and Allergen). Allergy 2008; 63 (Suppl 86):8-160.
9. Ceylan E, Gencer M, San I. Nasal polyps and the severity of asthma. Respirology 2007; 12:272-276.
10. Bilodeau L, Boulay ME, Boisvert P, Boulet LP. Asthma control and airway obstruction in asthmatic patients with versus without polypoid rhinitis. Am J Respir Crit Care Med 2007; 175:A198.
11. Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008; 372:1049-1057.
12. Braunstahl GJ, Kleinjan A, Overbeek SE, et al. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000; 161:1051-2057.
13. Braunstahl GJ, Overbeek SE, Kleinjan A, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001; 107:469-476.
14. Koinis-Mitchell D, Craig T, Esteban CA, Klein RB. Sleep and allergic disease: a summary of the literature and future directions for research. J Allergy Clin Immunol 2012; 130:1275-1281. doi: 10.1016/j.jaci.2012.06.026.
15. Havemann BD, Henderson CA, El-Serag HB. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut 2007; 56:1654-1664.
16. Theodoropoulos DS, Ledford DK, Lockey RF, et al. Prevalence of upper respiratory symptoms in patients with symptomatic gastroesophageal reflux disease. Am J Respir Crit Care Med 2001; 164:72-76.
17. Mastronarde JG, Anthonisen NR, Castro M, et al., American Lung Association Asthma Clinical Research Centers. This study assessed the efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009; 360:1487-1499.
18. Holbrook JT, Wise RA, Gold BD, et al., Writing Committee for the American Lung Association Asthma Clinical Research Centers. Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA 2012; 307:373-381.
19. Littner MR, Leung FW, Ballard ED 2nd, et al., Lansoprazole Asthma Study Group. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 2005; 128:1128-1135.
20. Harding SM, Richter JE, Guzzo MR, et al. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med 1996; 100:395-405.
21. Gibson PG, Henry R, Coughlan JJL. Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Revs 2003:CD-0-1496. doi: 10.1002/14651858.CD001496.
22. Bucca CB, Bugiani M, Culla B, et al. Chronic cough and irritable larynx. J Allergy Clin Immunol 2011; 127:412-419.
23. Watson MA, King CS, Holley AB, et al. Clinical and lung-function variables associated with vocal cord dysfunction. Respir Care 2009; 54:467-473.
24. Husein OF, Husein TN, Gardner R, et al. Formal psychological testing in patients with paradoxical vocal fold dysfunction. Laryngoscope 2008; 118:740-747.
25. Bateman ED, Kommann O, Schmidt P, et al. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. J Allergy Clin Immunol 2011; 128:315-322.
26. Peters SP, Kunselman SJ, Icitovic N, et al., National Heart, Lung, and Blood Institue Asthma Clinical Research Network. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010; 363:1715-1726.
27. Novelli F, Malagrinò L, Dente FL, Paggiaro P. Efficacy of anticholinergic drugs in asthma. Expert Rev Respir Med 2012; 6:309-319.
28. Kerstjens HAM, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med 2012; 367:1198-1207.
29. Shore SA. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol 2008; 121:1087-1093.
30. Pakhale S, Doucette S, Vandemheen K, et al. A comparison of obese and nonobese people with asthma: exploring an asthma-obesity interaction. Chest 2010; 137:1316-1322.
31. Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9:88.
32. Lessard A, Turcotte H, Boulet LP. Obesity and asthma: a specific phenotype? Chest 2008; 134:317-323.
33. Taylor B, Mannino D, Brown C, et al. Body mass index and asthma severity in the National Asthma Survey. Thorax 2008; 63:14-20.
34. Sutherland ER, Goleva E, Strand M, et al. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med 2008; 178:682-687.
35. Farah CS, Salome CM. Asthma and obesity: a known association but unknown mechanism. Respirology 2012; 17:412-421.
36. Aaron SD, Vandemheen KL, Boulet LP, et al. Over diagnosis of asthma in obese and nonobese adults. CMAJ 2008; 179:1121-1131.
37. Lang JE, Feng H, Lima JJ. Body mass index-percentile and diagnostic accuracy of childhood asthma. J Asthma 2009; 46:291-299.
38. Scott S, Currie J, Albert P, et al. Risk of misdiagnosis, health-related quality of life, and BMI in patients who are overweight with doctor-diagnosed asthma. Chest 2012; 141:616-624.
39. Eneli IU, Skybo T, Camargo CA Jr. Weight loss and asthma: a systematic review. Thorax 2008; 63:671-676.
40. Maniscalco M, Zedda A, Faraone S, et al. Weight loss and asthma control in severely obese asthmatic females. Respir Med 2008; 102:102-108.
41. Atlantis E, Sullivan T, Sartorius N, Almeida OP. Changes in the prevalence of psychological distress and use of antidepressants or antianxiety medications associated with comorbid chronic diseases in the adult Australian population, 2001-2008. Aust N Z J Psychiatry 2012; 46:445-456; Epub 2012 Jan 5.
42. Wang G, Zhour T, Wang L, et al. Relationship between current psychological symptoms and future risk of asthma outcomes: a 12-month prospective cohort study. J Asthma 2011; 48:1041-1050.
43. Fasmer OB, Halmøy A, Eagan TM, et al. Comorbidity of asthma with ADHD. BMC Psychiatry 2011; 11:128.
44. Fasmer OB, Halmoy A, Eagan TM, et al. Adult attention deficit hyperactivity disorder is associated with asthma. BMC Psychiatry 2011; 11:128; Published online 2011 August 7. doi: 10.1186/1471-244X-11-128.
45. Hasler G, Gergen PJ, Kleinbaum DG, et al. Asthma and panic in young adults: a 20-year prospective community study. Am J Respir Crit Care Med 2005; 171:1224-1230; Epub 2005 Mar 11.
46. Goodwin RD, Chuang S, Simuro N, et al. Association between lung function and mental health problems among adults in the United States: findings from the First National Health and Nutrition Examination Survey. Am J Epidemiol 2006; 165:383-388.
47. Tibosch MM, Verhaak CM, Merkus PJFM. Psychological characteristics associated with the onset and course of asthma in children and adolescents: a systematic review of longitudinal effects. Patient Educ Couns 2011; 82:11-19.
48. Urrutia I, Aguirre U, Pascual S, et al. Impact of anxiety and depression on disease control and quality of life in asthma patients. J Asthma 2012; 49:57-62; Epub 2011 Dec 16.
49. Heaney LG, Conway E, Kelly C, Gamble J. Prevalence of psychiatric morbidity in a difficult asthma population: relationship to asthma outcome. Respir Med 2005; 99:1152-1159.
50. Jaczku A, Panettieri RA Jr. Social stress and asthma: the role of corticosteroid insensitivity. J Allergy Clin Immunol 2010; 125:550-558.
51. Theoharides TC, Enakuaa S, Sismanopoulos N, et al. Contribution of stress to asthma worsening through mast cell activation. Aust N Z J Psychiatry 2012; 46:445-456; Epub 2012 Jan 5.
52. Goodwein RD, Pagura J, Cox B, Sareen J. Asthma and mental disorders in Canada: impact on functional impairment and mental health service use. J Psychosom Res 2010; 68:165-173.
53. Yorke J, Felming SL, Shuldham C. A systematic review of psychological interventions for children with asthma. Pediatr Pulmonol 2007; 42:114-124.